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Abstract. Phosphorylation of the Dictyostelium myosin 
II heavy chain (MHC) has a key role in regulating myo- 
sin localization in vivo and drives filament disassembly 
in vitro. Previous molecular analysis of the Dictyostel- 
ium myosin II heavy chain kinase (MHCK A) gene has 
demonstrated that the catalytic domain of this enzyme 
is extremely novel, showing no significant similarity to 
the known classes of protein kinases (Futey, L. M., 
Q. G. Medley, G. P. Crt6, and T. T. Egelhoff. 1995. J. 
Biol. Chem. 270:523-529).  To address the physiological 
roles of this enzyme, we have analyzed the cellular con- 
sequences of MHCK A gene disruption (mhck A- cells) 
and MHCK A overexpression (MHCK A ÷÷ cells). The 
mhck A- cells are viable and competent for tested myo- 
sin-based contractile events, but display partial defects 
in myosin localization. Both growth phase and devel- 
oped mhck A- cells show substantially reduced MHC 
kinase activity in crude lysates, as well as significant 
overassembly of myosin into the Triton-resistant cy- 
toskeletal fractions. MHCK A +  ÷ cells display elevated 
levels of MHC kinase activity in crude extracts, and 
show reduced assembly of myosin into Triton-resistant 
cytoskeletal fractions. MHCK A ÷  ÷ cells show reduced 
growth rates in suspension, becoming large and multi- 
nucleated, and arrest at the mound stage during devel- 
opment. These results demonstrate that MHCK A 
functions in vivo as a protein kinase with physiological 
roles in regulating myosin II localization and assembly 
in Dictyostelium cells during both growth and develop- 
mental stages. 
N 
'ON~USCLE myosin II is a major component of the 
cytoskeleton in eukaryotic cells, and is involved 
or implicated in a wide range of contractile events 
(34).  In  Dictyostelium  discoideum,  genetic  and  cellular 
studies have demonstrated essential roles for myosin II in 
cytokinesis, multicellular development, and receptor cap- 
ping (7, 12, 27). These studies have also demonstrated cen- 
tral roles for myosin II in cell locomotion and in mainte- 
nance of cortical tension (17, 27, 38). Although the roles of 
myosin II in nonmuscle cells are generally becoming clear, 
the mechanisms regulating localization and activity of my- 
osin II in these settings  are not well understood. Myosin 
light chain (MLC)  1  phosphorylation has a clear role in reg- 
ulating mammalian smooth and nonmuscle myosin II mo- 
tor function, and is also thought to participate in regula- 
tion of filament assembly in nonmuscle cells (36). Although 
phosphorylation of the myosin II heavy chain (MHC) has 
also been observed in several  types of mammalian non- 
muscle cells in a variety of settings  (4, 18, 23, 26), the de- 
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finitive  biochemical  consequences of MHC phosphoryla- 
tion in the mammalian systems are not known. 
In Dictyostelium, MHC phosphorylation plays a key role 
in regulating filament assembly both in vitro and in vivo. 
Two distinct MHC kinases  (MHCKs) have been purified 
to homogeneity from Dictyostelium. A  84-kD MHCK pu- 
rified by Ravid and Spudich (28) is expressed  only during 
development. A  130-kD MHCK (MHCK A) purified by 
Crt6 and Bukiejko (5)  is expressed  during both growth 
and developmental stages (Medley, Q. G., S. F. Lee, G. A. 
Cates, and G. P. Crtr. 1993. J. CellBiol.  115:29a). Both the 
130-kD MHCK A and 84-kD MHCK phosphorylate myo- 
sin on threonine residues and can drive  myosin filament 
disassembly in vitro (6, 28). The 130-kD MHCK A phos- 
phorylates threonine residues 1823, 1833, and 2029 in vitro 
(22, 37). The 84-kD  MHCK phosphorylates sites within 
the carboxyl-terminal  portion of the myosin molecule (7a, 
26a), but its exact  target sites have not been mapped. In 
addition to these two threonine-specific  MHCKs, evidence 
exists for other MHC kinase activities with specificity to- 
wards  threonine and serine  (20, 25). However, it is not 
known whether these other in vitro activities have physio- 
logical roles in regulating myosin function. 
The in vivo importance of the mapped MHCK A target 
sites  on the  MHC has been  demonstrated in  studies  in 
which the target sites were converted to either alanine (3X 
ALA myosin) or to aspartic  acid (3X ASP myosin) resi- 
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phorylatable MHC,  or pseudophosphorylated MHC, re- 
spectively. In vitro the  3X ALA myosin assembles  into 
bipolar filaments as efficiently as wild-type myosin while 
the 3X ASP myosin is unable to assemble at physiological 
salt conditions. In vivo 3X ALA myosin dramatically over- 
assembles into the cytoskeleton, while 3X ASP myosin is 
underassembled relative to wild-type cells.  Cells express- 
ing the 3X ALA myosin are competent for myosin depen- 
dent contractile events such as cytokinesis and develop- 
ment, although partial defects are  apparent.  In confocal 
microscopy studies,  cells expressing the  3X  ALA  MHC 
display a dramatic over localization of myosin to the corti- 
cal regions of the cells (14). In contrast, cells expressing 
the 3X ASP MHC are phenotypically identical to MHC 
null cells (MHC-), indicating that pseudophosphorylated 
MHC  cannot  participate  in  cellular  force  production. 
These studies indicate that the mapped MHCK A  target 
sites play a key role in regulating myosin II assembly into 
the cytoskeleton and that this assembly is required for my- 
osin function in vivo. 
At the primary sequence level the 84-kD  and 130-kD 
MHCKs are unrelated. The 84-kD enzyme displays signifi- 
cant similarity to members of the Protein Kinase C (PKC) 
family, particularly within  the  catalytic domain  (29).  In 
contrast, the primary sequence of the 130-kD MHCK A 
displays no significant similarity to any members  of the 
conventional classes  of eukaryotic protein  kinases. The 
protein consists of an amino-terminal domain predicted to 
have an c~-helical coiled-coil structure,  a  central domain 
believed to contain the catalytic functions, and a carboxyl- 
terminal domain which bears significant similarity to the 
13-subunit of heterotrimeric G proteins (13). In view of the 
novelty of this enzyme, the MHCK A gene was expressed 
in E. coli, and studies confirmed that the recombinant pro- 
tein was able to autophosphorylate and to phosphorylate 
the Dictyostelium MHC (13). 
A major unresolved question concerning myosin regula- 
tion in Dictyostelium is the physiological role of the multi- 
ple unrelated MHCKs. The studies reported here were de- 
signed to elucidate the role that the novel 130-kD MHCK 
A has in vivo by analyzing MHCK A null cell lines and cell 
lines overexpressing the cloned MHCK A  gene. Data ob- 
tained with MHCK A  null cell lines and cell lines overex- 
pressing the cloned MHCK A  gene demonstrate that this 
enzyme does exhibit MHC kinase activity in vivo, and that 
it influences myosin localization and assembly during both 
growth and development. 
Materials and Methods 
Dictyostelium  Growth and Development 
Dictyostelium discoideum strain JH10 (15) was employed as the parental 
cell type for the studies described here. Cells were cultured axenically on 
plastic petri dishes in HL5-medium (35) supplemented with 100 U/ml pen- 
icillin, 100 ~,g/ml streptomycin, and 100 ixg/ml thymidine. For suspension 
growth analysis cells were transferred from petri dishes to small Eden- 
meyer flasks for ~24 h to allow adaptation to suspension growth, and then 
adjusted to a low cell density. Cultures were rotated at 200 rpm at 21°C 
and cells were counted daily. Each cell line was inoculated in triplicate 
and counted independently. Doubling times were determined for cultures 
during log phase growth, and values from each triplicate culture averaged. 
For developmental studies cells were harvested in log phase growth and 
plated on filter membranes as described (35).  The cell line HS1 (31) was 
used as an MHC- control for some experiments. 
Plasmid Constructs  and Transformations 
All DNA manipulations were performed using standard laboratory meth- 
ods (32).  Brief description of plasmid constructions are given below. Full 
details  of  all  constructs  are  available  upon  request.  To  construct  an 
MHCK gene replacement cell line, a gene replacement vector was made 
as follows. A 0.9-kb ClaI-AccI fragment containing the 5' flanking region 
of mhck A gene, and a 1.1-kb ClaI-EcoRI fragment containing the 3' por- 
tion of the gene were isolated from size selected plasmid libraries of Dictyo- 
stelium DNA using the mhck A cDNA as a probe. The gene replacement 
vector, pDF15, was generated by ligating the 0.9-kb ClaI-AccI fragment 
and 1.l-kb ClaI-EcoRI fragment into the vector pTZ18 (Pbarmacia Bio- 
tech) with the Dictyostelium  Thyl  gene (9) between the genomic frag- 
ments. The Thyl gene was isolated from the plasmid pThy-Short (a gift 
from K. Ng and G. Nuckolls, Stanford University). The plasmid pThy- 
Short contains the Thyl marker isolated by Dynes and Firtel (9), except 
that 1.1 kb of genomic DNA upstream of the Thyl promoter has been re- 
moved by Exonuclease III and $1 nuclease digestion as follows. The 3.2- 
kb Thyl marker from pGEM26 was cloned as an SalI fragment into the 
XhoI site of pGEM7 (Promega, Madison, WI). This plasmid was digested 
with EcoRI and Sacl, which both cut the polylinker on the 5' end of the 
Thyl fragment. Several progressive deletions of the Thyl fragment were 
created using the Erase-a-Base system (Promega). pThy-Short was the 
smallest fragment produced in this approach that complimented the Thy- 
defect when transformed into the Dictyostelium cell line JH10. 
Plasmid pDF15 was linearized at polylinker restriction sites immedi- 
ately adjacent to the 5' and 3' segments of homology to promote recombi- 
nation at the mhck A locus. The thymidine-auxotrophic cell line JH10 was 
electroporated with 5 g of restricted pDF15 and transformants were se- 
lected in HL-5 medium lacking thymidine. Colonies were picked around 
the seventh day and transferred to 12-well  microtiter plates. The isolated 
colonies were screened for the absence of MHCK A by Western blotting 
using an anti-MHCK A monoclonal antibody (13).  Of fourteen indepen- 
dent isolates originally screened, twelve showed no reactivity with the 
anti-MHCK A antiserum. Four of these cell lines were analyzed by South- 
ern blotting and all appeared to be gene replacement events generated via 
double  recombination at the 5'  and 3'  homology segments. JH10 cells 
transfected with pThy-Short (referred to as JH10 thy +  cells) were used as 
a control for cell biological studies of mhck A- cells. 
Southern Blot Analysis 
Genomic Southern blot analysis of the mhck A  locus was performed on 
parental  (JH10)  and four independent transformed cell  lines that had 
tested negative for MHCK A expression by Western blot analysis. DNA 
was isolated and purified by CsCI density gradients from parental and 
MHCK A null cell lines. After digestion of DNA with Xbal, 0.6 ~g DNA 
was loaded onto a 0.8% agarose gel, electrophoresed, and transferred to 
GeneScreen Plus membrane (New England Nuclear Research Products, 
Boston, MA). The filters were hybridized with 32p-labeled cDNA probes 
following GeneScreen Plus protocols. Probe A is a 1.1-kb ClaI-BclI frag- 
ment containing 0.9 kb of mhck A 5' flanking region and 0.2 kb of mhck A 
coding sequence. Probe B corresponds to a 1.7-kb KpnI-Kpnl restriction 
fragment of the mhck A cDNA. 
MHCK A Overexpressing Cells 
The Dictyostelium mhck A cDNA was fused to the Dictyostelium actin 15 
promoter, so that codon 8 of the actin 15 gene is fused to codon 7 of mhck 
A. This modified mhck A gene was then cloned into the expression vector 
pLittle (constructed by Dr. T. Q. P. Uyeda, NAIR, Japan, unpublished) to 
generate pLMHCK, pLittle is a derivative of pBIG (31) which contains 
part of the native Dictyostelium extrachromosomal plasmid Ddp 1, a G418 
resistance cartridge, and E. coil replication functions. The plasmid pLittle 
differs from pBIG in that a 1.5-kb KpnI fragment in the Ddpl portion of 
pBIG was removed. The plasmid pLMHCK was introduced into the mhck 
A- cell line by electroporation, grown overnight in HLS, and then trans- 
formants were  selected in the presence of 8  g/ml G418.  Colonies were 
picked after ~5 d, transferred to microtiter plates for clonal growth, and 
then screened for the presence of MHCK A  by Western blot analysis. In 
early studies it was demonstrated that the actin 15 promoter expression 
level increases significantly during development (19). In more recent stud- 
ies using this promoter to  drive myosin expression from extrachromo- 
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served during growth phase as well. 
Generation of Polyclonal Antiserum 
A portion of the MHCK A cDNA corresponding to amino acids 7-656 was 
expressed in E. coli using the expression vector pET21d (Novagen, Madi- 
son, WI). The resultant fusion protein contains a (His)6 carboxyl-terminal 
tag  which allows  purification  using metal ion  affinity chromatography 
methods as described by the pET21 vector supplier. Approximately 200- 
300 g of affinity-purified protein was injected into a New Zealand white 
rabbit at 4-wk intervals, with serum collected 12-14 d later. Cleared serum 
was used at 1:1,000 dilution for Western blots. 
Polyclonal antiserum against Dictyostelium  myosin was made by inject- 
ing rabbits with purified myosin using a similar schedule to that described 
above. For Western blot analysis the anti-myosin antiserum was used at a 
1:1,000  dilution, followed by alkaline pbosphatase conjugated secondary 
antibody, and development with BCIP (5-bromo-4-chloro-3-indoyl phos- 
phate p-toluidine salt) and NBT (p-nitro blue tetrazolium chloride) (16). 
Western Blot Analysis 
Cells were harvested from plates, washed with 15 mM Tris, pH 7.5, and re- 
suspended in buffer containing 50 mM Tris, pH 8.0, 20 mM NaPPi, 5 mM 
EDTA, 5 mM EGTA, 0.5% Triton X-100, I g/ml leupeptin, 1 g/ml pepsta- 
tin, and 10 g/ml PMSF. An equal volume of 2x  Sample buffer (50 mM 
"Iris, pH 6.8, 4% SD8,10% glycerol, 50 l/ml 2-mercaptoethanol, and 0.2 g/ml 
bromophenol blue) was then added and samples were then immediately 
boiled  for  5  min  and  subjected  to  SDS-PAGE.  Samples  were  either 
stained with Coomassie blue or transferred to nitrocellulose and probed 
with MHCK A  monoclonal or polyclonal antibodies. Signal was detected 
using either an alkaline phosphatase-linked goat anti-rabbit antibody or 
~25I-goat anti-mouse antibody. 
Myosin Phosphorylation  and Immunoprecipitation 
Myosin was phosphorylated in cell lysates as previously described by Bet- 
lot et al. (2), with modifications described below. Cells were washed with 
15 mM Tris, pH 7.5. 150 txl of cells (3 ×  106) in 15 mM Tris were added to 
150 txl of a reaction mixture containing 0.2% Triton X-100, 4 mM MgCI2, 
4 mM MnC12, 7.5 mM Tris, 10 p,M ATP, and 100 Ci/mmol [~/-3ZP]ATP and 
incubated on ice for 5 min. Reactions were stopped by adding an equal 
volume of either ice-cold 5%  TCA or 2  x  immunoprecipitation buffer 
(IP) containing 150 mM NaCI, 1% Triton X-100, 15 mM Tris-HC1, pH 7.5, 
2 mM NAN3, 5 mM EDTA. 
Pansorbin (Calbiochem) (50 1) and anti-myosin polyclonal antiserum 
(10 1) were mixed with IP buffer (100 1), rotated at 4°C for 4-18 h, and 
washed three times with IP buffer, Myosin was immunoprecipitated using 
denaturing conditions. An equal volume of 100 mM Tris, pH 8.0,  10 mM 
EGTA,  10 mM EDTA, 2%  SDS,  4  mM ATP,  100  mM NaF1,  50  mM 
NaPPi, 10 p,M okadaic Acid, 20 p.g/ml pepstatin, 50 ixg/ml L-l-chloro-3-[4- 
tosylamido]-7-amino-2-heptanone-HCl (TLCK),  and  10  i~g/ml  PMSF) 
was added to the lysates and samples were immediately boiled for 10 min. 
Pansorbin (4 Ixl) was added and the lysates were cleared by centrifugation 
at top speed in a microfuge for 5 rain. The supernatant was transferred to 
a fresh tube containing 1 ml of IP buffer containing the preadsorbed Pan- 
sorbin-myosin polyclonal antibody complex described above and mixed 
overnight with  end-over-end rotation  at  4°C.  The  immunoprecipitated 
myosin was washed as described in (30) with minor modifications. Briefly, 
the Pansorbin pellet was washed two times with IP buffer containing 0.2% 
SDS, washed two times with 2 M urea, 200 mM NaC1,  1% Triton X-100, 
100 mM Tris-HC1, pH 7.5, 2 mM NAN3, 5 mM EDTA, once with 500 mM 
NaCI, 1%  Triton X-100, 20 mM Tris-HCl, pH 7.5, 2  mM NaN  3, 5  mM 
EDTA, and once with 50 mM NaCI, 10 mM Tris-HC1, pH 7.5, 2 mM NAN3, 
5 mM EDTA. The final complex was then boiled in SDS sample buffer, 
spun to remove the Pansorbin and soluble material was then subjected to 
SDS-PAGE. 
Phosphoaminoacid  Analysis 
After SDS-PAGE, myosin was transferred electrophoretically to Immo- 
bilon P membrane (Millipore, Bedford, MA) and stained with Ponceau to 
visualize protein bands. The myosin band was excised, wetted in methanol 
and rinsed with 1 ml water three times to remove any residual transfer 
buffer. Phosphoaminoacid Analysis (PPA) was performed according to 
Boyle et al. (3). The myosin was hydrolyzed with 5.7 N HCI and incubated 
for 4 h at ll0°C to optimize for recovery of phosphothreonine. The super- 
natant was transferred to a fresh tube and lyophilized in a Speed Vac con- 
centrator, and washed three times with 1 ml water. The samples were elec- 
trophoresed at pH 1.9 (formic acid/glacial acetic acid/water, 50:156:1794) 
on cellulose thin-layer plates using the Hunter thin layer electrophoresis 
unit (CBS Scientific, Del Mar, CA). The positions of the phosphopeptide 
standards were visualized by staining with 0.25% (wt/vol) ninhydrin in ac- 
etone. 
Isolation  of Triton-insoluble  Cytoskeletons 
Triton-insoluble cytoskeletons were isolated as described previously (10) 
with modifications described below. Cells (1.5 x  106) were washed twice 
in 15 mM Tris, pH 7.5, and resuspended in 150 ~l of 100 mM MES, pH 6.8, 
2.5 mM EGTA, 5 mM MgC12 and 2 mM ATP at 0°C. An equal volume of 
the same buffer containing 1% Triton X-100, 0.1 mg/ml PMSF, 10 mg/ml 
pepstatin, and 50 p,g/ml TLCK was added. The suspension was vortexed 
5 s, and centrifuged for 2 min in a microfuge. Supernatants and Triton- 
insoluble pellets were resuspended in SDS gel sample buffer, heated to 
100°C for 5 rain, and subjected to SDS-PAGE on 8% gels. Duplicate sam- 
ples were run, with one set stained with Coomassie blue and the other set 
used for  Western blot  analysis. Coomassie blue stained myosin bands 
from the supernatant and pellet fractions were quantitated by densitome- 
try. The percent myosin in the cytoskeleton was calculated for each indi- 
vidual sample by dividing the value for MHC in the cytoskeletal pellet by 
the sum of the pellet and supernatant MHC values for that sample. This 
"%" cytoskeleton value was then averaged for multiple-independent sam- 
ples to produce the values shown in Fig. 5 C. The "*" for MHCK A ++ cell 
line values indicate that these are estimates. MHC levels in the cytoskele- 
tal pellets for these cell lines were consistently too low for accurate densi- 
tometry from Coomassie-stained gels. 
Results 
Elimination and Overexpression of MHCK A 
The gene encoding MHCK A was eliminated from Dictyo- 
stelium by homologous recombination. The gene replace- 
ment construct contained the Dictyostelium Thyl gene in- 
serted  between  5'  and  3'  flanking  sequences  from  the 
mhck A gene (Fig. 1 A). After introduction of the replace- 
ment construct into JH10 cells, 14 transformants were iso- 
lated  for Western  blot  analysis with  a  monoclonal  anti- 
body generated against the native MHCK A. Of these cell 
lines, 12 had no detectable MHCK A expression. 
Genomic DNA was isolated from three  of the  twelve 
antibody-negative  cell  lines  and  used  for  Southern  blot 
analysis. All three cell lines displayed identical  Southern 
blot profiles. The results for one line are shown in Fig. 1 B. 
The wild-type mhck A  locus resides on an 8-kb XbaI re- 
striction  fragment,  and  in  a  double  cross-over gene  re- 
placement,  this  fragment  should  be  replaced  by a  6-kb 
XbaI restriction fragment containing the Thyl gene (Fig. 1 
A). Filters incubated with a mixed probe comprised of a 5' 
ClaI-BclI fragment (probe A; see Fig. 1 A) and a central 
KpnI fragment (probe B) demonstrate the presence of the 
8-kb XbaI fragment in the wild-type JH10, and the 6-kb 
XbaI fragment in the mhck A  disruption cell line (Fig.  1 
B). A duplicate filter incubated only with probe B demon- 
strates  the  presence  of the  8-kb  restriction  fragment  in 
JH10, but yielded no signal in the mhck A  disruption cell 
line  (Fig.  1 B), indicating that a  clean gene replacement 
event had occurred. 
MHCK A was overexpressed in the mhck A- cell line by 
fusing the MHCK A cDNA to the actin 15 promoter in the 
extrachromosomal vector pLittle. Fig. 2 shows a Western 
blot of whole cell extracts from control (JH10 thy+), mhck 
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Figure 1.  Generation of the 
Dictyostelium mhck A-  cell 
2  3  4  5  6  7  8  lines. (A) Schematic  of gene 
~  ~  ~  t  ~  ~  ~  replacement  construct,  the 
~  _o  oo  wild-type Dictyostelium mhck 
• 9 ~  ~ 1.~  ~  geaomplaeement  A  structure,  and  the  dis- 
!  ,"" J  ll-r¢ I (1,s I~)J.,  construct  rupted  mhck A-  locus.  Ho- 
~,,"  "':\,,  mologous recombination be- 
"[~<Tt  ~  ~  ~\',,,, ~  ~  tween  the  targeting  vector 
[['6".~il ~  S  s  dructum  nates the mhck A  gene and 
rr~ckA  (a,S ~i  I I  '11'r"11 0.a I  w.t.  rah~ A  ~ne  and the wild-type gene elimi- 
t  i  i  '~og.A  mo~B  replaces  it  with  the  Thyl 
gene. Shaded  segments cor- 
~  ~  ~  ~  respond  to  genomic  DNA 
I °~ I  I 1.1  io,8  1  rahckAtel~c~'aenl  flanking  the MHCK A  gene 
rmlo.a~)  gene=tructure  which  was  cloned  into  the 
gene  replacement construct. 
The dotted lines indicate pre- 
dicted homologous recombination regions. (B) Genomic Southern  blot analysis of the mhck A locus in parental (JH10) and mhck A- 
cells. DNA from both parental and mhck A- cell lines was digested with XbaI, and subjected  to Southern analysis. Filters were incu- 
bated with a ClaI-Bcll DNA fragment which includes 5' noncoding DNA and some coding region sequences (Probe A) together with a 
KpnI-KpnI DNA fragment which lies completely within the rnhck A coding region (Probe B), or with probe B alone. 
A-, and MHCK A ÷÷ cell lines. In the MHCK A ÷÷ cells 
MHCK A  is overexpressed ,',~30-fold during growth phase 
relative to control cells as quantified by phosphorimaging 
of Western blots performed with 125I-anti-mouse second- 
ary antibody. 
Myosin Phosphorylation 
Previous  studies  have  demonstrated  that  the  myosin 
heavy  chain  is  phosphorylated  primarily  on  threonine 
and serine residues in cells lysed with Triton X-100 con- 
taining ['y-a2p]ATP (1, 11). We performed in vitro labeling 
and phosphoamino acid analysis of myosin isolated from 
mhck A- and MHCK A +  + cell lines to determine what ef- 
fect  alterations  in  MHCK A  abundance  would  have  on 
phosphorylation in crude lysates. Fig. 3 shows phosphory- 
lation of MHC in Triton X-100 cell lysates from growth 
phase control, mhck A-  and MHCK A ÷+ cell lines. Ali- 
quots of growth phase cells were lysed with Triton X-100 
in the presence of [~,-32p]ATP, and then the myosin was im- 
munoprecipitated  as  described  above.  Autoradiographic 
analysis of these  samples indicates that the  myosin from 
mhck A- cells was significantly less phosphorylated than 
myosin from control cells (Fig.  3 B).  In contrast MHCK 
A ÷÷ cells displayed elevated MHC phosphorylation rela- 
Figure 2.  Expression  of the 
MHCK  A  protein.  Western 
blot analysis of MHCK A ex- 
pression  in  control  (JH10 
thy÷), rnhck A-,  and  rnhck 
A- cell line transformed with 
pLittle expressing  MHCK A 
(MHCK  A÷+).  Molecular 
size standards  are shown  on 
the  left.  Filter  was  probed 
with a polyclonal rabbit anti- 
serum  produced  against  re- 
combinant MHCK A protein 
and developed enzymatically. 
tive to the control cell line in this assay (Fig. 3 B). Phos- 
phoaminoacid analysis of immunoprecipitated MHC indi- 
cated  that  the  myosin was  primarily phosphorylated  on 
threonine residues in control cells, as well as MHCK A +  ÷ 
cells.  In experiments performed with significantly higher 
specific activity [-,/-32p]ATP it was observed that the resid- 
ual phosphorylation in extracts of rnhck A- cells was also 
primarily on threonine (data not shown). 
We also examined myosin phosphorylation during  de- 
velopment of Dictyostelium cells. Control, mhck A-, and 
MHCK A ÷+ cells were developed on filter pads and har- 
vested at 0, 6, and 16 h into development and phosphory- 
lated in vitro as described above (Fig. 4). Myosin was im- 
munoprecipitated and subjected to SDS-PAGE followed 
by staining with Coomassie blue. The level of MHC phos- 
phorylation for each sample (quantified by phosphorimag- 
ing) was normalized to the amount of MHC in each sam- 
ple (quantified by densitometry of the Coomassie-stained 
gel) so that relative MHC phosphorylation in each sample 
could be compared. The rate of myosin phosphorylation in 
crude extracts did not change significantly during develop- 
ment in any of the three cell lines. 
Myosin Assembly into the Cytoskeleton in mhck A- and 
MHCK A ÷  ÷ Cell Lines 
To address the localization properties of myosin in mhck 
A- and MHCK A ÷+ cell lines Triton-insoluble cytoskele- 
tons were isolated from the mutant cell lines. Lysed cells 
were  fractionated  by centrifugation  into  soluble  and  cy- 
toskeletal components and subjected to SDS-PAGE. 
Fig.  5 presents a  typical cytoskeletal fractionation pat- 
tern  for growth  phase  cells  after  SDS-PAGE  and  Coo- 
massie blue staining (panel A) or after Western blot analy- 
sis (panel B).  In control cells the majority of the  myosin 
fractionated  in  the  soluble  fraction  (Fig.  5,  A  and  B,  S 
lanes),  while  in  mhck  A-  cells  approximately threefold 
more myosin fractionated with the cytoskeleton (Fig. 5, A 
and B, P  lanes). MHCK A ÷+ cells had most of the myosin 
associated  with  the  soluble  fraction  (Fig.  5,  A  and  B,  S 
lanes). 
The Journal of Cell Biology, Volume 132,  1996  104 Figure 3. Phosphorylation of myosin in Triton X-100 lysates in growth phase Dictyosteliurn. After phosphorylation in Triton lysates with 
[-¢-32p]ATP, myosin was immunoprecipitated and subjected  to SDS-PAGE, followed by phosphoamino acid analysis (PAA). (A) Coo- 
massie-stained  gel of immunoprecipitated myosin. Lane 1, myosin from control cells (JH10 thy+); lane 2, myosin from mhck A- cells; 
lane 3, myosin from MHCK A +÷ cells; lane 4, lysates of MHC- cells used as negative control. The myosin heavy chain migrates at 244 
kD, and the IgG heavy chain migrates  at ~53 kD. (B) Autoradiogram of gel shown in A. (C) Phosphoamino acid analysis of myosin 
from control, rnhck A- and MHCK A ÷+ cell lines labeled in crude extracts. Myosin was immunoprecipitated as in A, and then blotted to 
Immobilon P and subjected  to PAA analysis. Dotted lines indicate origin and positions of phosphoserine  (P-Ser) and phosphothreonine 
(P-Thr) standards included in electrophoresis run. 
Quantification of a series of Triton-fractionated samples 
from both growth phase cells and cells starved for 4 h was 
performed  by  densitometry  of  Coomassie  blue-stained 
gels (Fig. 5 C). This analysis indicated that in growth phase 
cells 8.8% (--+1.2) of the myosin from control ceils fraction- 
ated  with  the  cytoskeletal fraction, 24.9%  (_+2.4)  of the 
myosin from rnhck A- cells fractionated with the cytoskel- 
eton, and <4%  of the myosin from MHCK A ++ cell lines 
fractionated with the cytoskeleton. In control cells starved 
4 h 8.0% (_+1.1) of the myosin was associated with the cy- 
toskeleton, while 21.5%  (+--1.8) of the myosin from mhck 
A- cells fractionated with the cytoskeleton. MHCK A ++ 
cells had <4% of the myosin associated with the cytoskel- 
eton.  Therefore,  in  both  growth  phase  and  developed 
mhck A- cells, myosin consistently overassembled into the 
cytoskeleton. 
Growth Rates and Cytokinesis 
The mhck A- and MHCK A + + cell lines grown on plastic 
petri dishes showed similar growth rates as compared to 
control  cells.  To  assay competence  for cytokinesis,  cells 
were grown in suspension culture as previously described 
(10, 11).  In this setting myosin function is essential for cell 
division (7, 24). When placed in suspension culture, cells 
lacking myosin II become large and multinucleated, even- 
tually lysing. Parallel suspensions of control (JH10 thy +) 
and mhck A- cells grew with a doubling time of 10.2 +-_ 0.2 h 
and 12.3  -+ 0.2 h, respectively (Fig. 6 A). To directly corn- 
pare growth rates of the MHCK A ÷+ cell line (which car- 
ries a G418-resistance extrachromosomal plasmid) to other 
cell lines, control, mhck A-,  and MHC- cells were trans- 
fected with the  vector pLittle to confer G418 resistance. 
Analysis of doubling  times was then performed with  all 
cell lines in the presence of G418 (8 I~g/ml)  to adjust for 
the slower growth that occurs in the presence of this anti- 
biotic (Fig. 6 B). Control-pLittle cells doubled every 20.8  ___ 
0.5  h  while rnhck A--pLittle cells showed a  small but re- 
producible  decrease in growth rate in late log phase and 
doubled  every 23.6  -+  0.7  h.  mhck A-  -pLittle  cells  re- 
mained  of  normal  size,  were  generally  mononucleated, 
and  eventually grew to a  similar density as control cells. 
MHCK A ++ cells displayed a slower than normal growth 
rate doubling every 27.9  ___ 2.6 h, displayed frequent multi- 
nucleation  while  in  suspension  culture,  and  grew  to  a 
lower  final  density  as  compared  to  control-pLittle  and 
mhck A--pLittle cells. MHCK A + + cells increased in size 
during the first several days in suspension and with some 
cell lysis. However, in contrast to myosin null cell these cells 
are able to grow in suspension indicating that these cells are 
at least partially competent to carry out cytokinesis. 
Development 
Myosin null cells arrest at the mound stage and are unable 
to complete development, indicating that myosin function 
is  essential  for  morphogenensis  (7).  To  assess  roles  of 
MHCK  A  during  development,  control,  mhck  A-,  and 
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Figure 4. Phosphorylation  of myosin in growth phase and starved 
Dictyostelium.  Control  cell  lines  (JH10  thy+), mhck A-,  and 
MHCK A ÷÷ were developed on filter pads for 0, 6, or 16 h. Cells 
were collected and lysates were phosphorylated in vitro, followed 
by immunoprecipitation  of myosin and SDS-PAGE. The top por- 
tion of figure shows autoradiogram of immunoprecipitated myo- 
sin from each time point. Bar graph indicates the relative myosin 
heavy chain phosphorylation level of each sample as determined 
by phosphorimaging  and densitometry (32p counts/U myosin). 
MHCK A++cell lines were allowed to develop on filters. 
The  mhck  A-  cells were  able  to  develop normally  and 
formed fruiting bodies at rates (~24 h) comparable to con- 
trol cells (Fig. 7, A  and B). In addition, mhck A- cells dis- 
played slug migration rates similar to control cells when 
tested  on water-agar plates  during phototaxis  (35)  (data 
not shown). MHCK A ÷ ÷ cells arrested at the mound stage 
and were unable to complete development (Fig. 7  C). In 
some  experiments  partial  development was  observed in 
MHCK A +÷ cells after 4-5 d  on filter pads, but this pat- 
tern was not consistent. 
Discussion 
We have used targeted homologous recombination of the 
mhck A  gene to produce Dictyostelium cells that lack the 
MHCK A  protein. Southern blot analysis of these cells in- 
dicated that the mhck A  gene was eliminated and a single 
copy of the  Thyl  gene was inserted at the mhck A  locus. 
Western blot analysis of the mutant cell lines showed that 
no MHCK A polypeptide was expressed in mhck A- cells, 
and revealed a 30-fold increase in MHCK A  expression in 
mhck A- cells transfected with the MHCK A  gene on an 
extrachromosomal vector. 
The MHCK A  protein kinase is unusual in that at the 
primary sequence level it displays no detectable similarity 
to known classes of protein kinases (13). The results pre- 
sented  here  provide strong  evidence  that  the  biochemi- 
cally  identified  MHCK  A  protein  does  function  as  an 
MHC kinase  in  Dictyostelium,  and  that  it  has  a  specific 
role regulating myosin localization in vivo. 
In previous studies MHC phosphorylation analysis was 
performed in crude lysates, or in lysates partitioned into 
cytoskeletal  and  soluble  fractions  (1,  2).  Those  studies 
demonstrated  that  virtually  all  MHC  kinase  activity  in 
crude lysates cofractionates with the Triton-insoluble cy- 
toskeleton. Furthermore, it was observed in those studies 
that when lysates were prepared from cells stimulated with 
the chemoattractant cAMP, a transient increase in myosin 
assembly into the cytoskeleton occurred N40 s after stimu- 
lation. This increase in assembled myosin was observed to 
coincide temporally with an increase in MHC phosphory- 
lation rate in such lysates. It was proposed that myosin as- 
sembly into the cytoskeleton in response to cAMP might 
increase substrate availability to cytoskeletally associated 
MHC kinase activities, resulting in the observed increase 
in MHC phosphorylation rate (1). 
The in vitro phosphorylation analysis presented  in  the 
current  work  indicates  that  the  majority of the  in  vitro 
MHC  kinase  activity  in  Triton  X-100  lysates  is  due  to 
MHCK A.  In mhck A-  cells, N90%  of the MHC kinase 
activity in such lysates is absent. This result, together with 
the  elevated  level  of  MHC  kinase  activity  in  MHCK 
A++cell lysates, indicates that MHCK A  is the major ac- 
tivity that phosphorylates MHC in crude lysates. It is im- 
portant to note the same pattern was observed in lysates of 
growth phase cells, and in lysates of cells developed on fil- 
ter pads for 6 or 16 h. MHCK A  appears to be the major 
MHC kinase activity in crude lysates in all these settings, 
and appears to be the major activity previously observed 
in in vitro studies (1). We believe that in vitro phosphory- 
lation in this assay represents phosphate incorporated into 
myosin which was not phosphorylated at the time of cell 
lysis.  If MHCK A++cells have  elevated levels of in vivo 
MHC phosphorylation,  there  may be less  available sub- 
strate in these extracts, so that the increase in phosphory- 
lation is smaller than one might expect given the 30-fold 
overexpression of MHCK A  in these cells. The converse 
also may be true in the rnhck A -cells; reduced MHC phos- 
phorylation at MHCK A target sites may allow an increase 
in the apparent phosphorylation rate in vitro by other ki- 
nases present in the mhck A-  cells.  Cold ATP chase ex- 
periments (unpublished  observation and see reference 1) 
indicated  very little dephosphorylation of MHC in  these 
Triton extracts, suggesting that no significant turnover of 
phosphate occurs in these assays. 
These results do not preclude roles for other MHC ki- 
nase  activities in  the  in  vivo control of myosin function. 
Strong in vitro evidence exists for the  importance of the 
84-kD  PKC-like  MHCK  in  controlling  myosin  function 
(28, 29), and it is likely that the developmentally expressed 
PKC-like enzyme has developmental-specific roles as well. 
The predominant role of MHCK A  in MHC phosphoryla- 
tion in crude extracts may be due to either high activity of 
this enzyme in such lysates, or to a physical interaction be- 
tween MHCK A  and myosin which enhances the relative 
activity of this kinase in vitro. 
The Triton-resistant cytoskeleton analysis of the mhck 
A-  and  MHCK A +÷  cell lines provide further  evidence 
that this kinase plays a key role in controlling myosin as- 
sembly into  the  cytoskeleton.  Previous  analyses  of site- 
The Journal of Cell Biology, Volume 132, 1996  106 Figure 5.  Isolation of Triton-insoluble  cytoskeletons.  Cells were lysed with buffer containing Triton X-100 at 0°C and centrifuged at 4°C 
for 2 min to pellet cytoskeletal  ghosts. The soluble cytosolic fractions  (S) and the cytoskeletal  pellet (P) were subjected  to SDS-PAGE 
and either stained with Coomassie blue (A), or transferred to nitrocellulose filters for Western blot analysis probed with polyclonal anti- 
myosin antiserum (B). Arrowheads indicate position of MHC. Samples in panels A and B are from growth phase cells. Panel C presents 
densitometry values for cytoskeletal  fractions from growth phase and 4 h developed cells. Error bars represent SEM, n = 12. Asterisks 
indicate values for which the MHC bands were too faint for accurate densitometry. 
directed mutants of MHC phosphorylation sites provide a 
useful model for assessing the phenotypes of mhck A- and 
MHCK A ÷÷  cell lines.  Cells containing  myosin which is 
nonphosphorylatable at MHCK A  target sites (3X ALA 
cells) or which is pseudophosphorylated by introduction of 
aspartate  residues  (3X  ASP  cells)  display  overassembly 
and  underassembly  of myosin into  the  cytoskeleton,  re- 
spectively (11). In this context the overassembly of MHC 
into  the  cytoskeleton  in  mhck  A-  cells  indicates  that 
MHCK A  functions during both growth and development 
to modulate myosin assembly into the cytoskeleton. This 
interpretation is further supported by the underassembly 
of myosin in MHCK A ÷÷ cells. It should be noted that ab- 
solute  myosin  recovery  in  Triton-cytoskeletal  fractions 
varies depending on exact conditions (ATP concentration, 
Ca  2+ concentration, temperature, etc.; unpublished obser- 
vations and see references 8, 11, 33). Of more importance 
is  the  relative  difference  between  different  cell lines  as- 
sayed in parallel under identical conditions. In this regard, 
clear differences are present between the wild-type, mhck 
A-, and MHCK A ÷÷ cells. 
Analysis of growth rates in suspension revealed a slight 
but  reproducible  decrease  in  rate  in mhck A-  cells.  Al- 
though  small,  this  effect is consistent with  a  modulatory 
role for MHCK A  in either cytokinesis or growth in gen- 
eral. It is noteworthy that a similar but more severe effect 
was observed previously in the  3X ALA  MHC mutants, 
which  display  more  dramatic  myosin  overassembly into 
the cytoskeleton (11). Cells expressing the 3X ALA MHC 
had ~80%  of cellular myosin associated with the Triton- 
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Figure  6.  Growth  curves  of cells in  suspension 
cultures.  (A)  Cultures  inoculated  at  0.5  ×  105 
cells/ml were  grown  in  suspension  in  HL5  and 
rotated  at  200  rpm.  (B)  Cultures  inoculated  at 
105  cells/ml were  grown  in  suspension  in  HL5 
with 8 ixg/ml G418 (all cell lines transfected with 
pLittle or pLittle derivatives) and rotated at 200 
rpm. Density was determined by hemocytometer 
counts.  Error bars  represent  SEM for triplicate 
samples. Error is smaller than symbols for some 
samples. 
Kolman et al. Myosin Heavy Chain Kinase A  107 Figure  7.  Synchronous  morphogenesis  on filters.  Synchronous 
morphogenesis  was performed by plating cells on filter pads in 
Lower Pad Solution (35). (A) Control (JH10 thy÷), (B) mhck A-, 
and (C) MHCK A +÷. Development appeared complete  by 24 h, 
photograph was taken at 48 h. 
insoluble cytoskeleton,  and displayed very long doubling 
times in suspension relative to control cells. 
Overexpression  of MHCK A  produces a partial defect 
in cytokinesis, again similar but less severe than that of the 
previously characterized 3X ASP MHC mutants which ex- 
press pseudophosphorylated MHC (11). No detectable de- 
fect  was  observed  in  rates  of  development  in mhck  A- 
cells, while MHCK A ÷ ÷ cells were blocked at the mound 
stage.  All  of the  growth  and  developmental  phenotypes 
observed in the current study are consistent with the phe- 
notypes previously observed in 3X ALA and 3X ASP my- 
osin cells, and are furthermore consistent with the model 
that MHCK A  participates in regulation of myosin local- 
ization  in  vivo.  These  results  also  indicate  that  partial 
overassembly of myosin into the cytoskeleton is not highly 
deleterious,  but  that  hyperphosphorylation of  MHC  by 
MHCK A  (in MHCK A ÷÷ cells) inhibits assembly into the 
cytoskeleton  and  that  this  significantly  reduces  myosin 
function in vivo. 
The relationship between MHCK A  and other MHCKs, 
particularly the 84-kD PKC-like MHCK, is not well under- 
stood.  In  addition  to  that  MHCK,  other  activities  have 
been observed that phosphorylate MHC on serine as well 
as  threonine  (20, 25).  A  firm  understanding of the  rela- 
tionships between  these  kinases  will  require  cloning and 
gene  disruption of the genes encoding these activities.  A 
notable  discrepancy  between  the  properties  of 3X  ALA 
cells and rnhck A-  cells is that the former  cells  assemble 
~80%  of their myosin into Triton-resistant cytoskeletons 
while the latter ceils assemble only ~25%.  While there is 
clear  overassembly  of myosin in the mhck A-  cells,  this 
difference  implies that there are other physiologically im- 
portant MHC  kinases  which participate  in regulation  of 
myosin localization during both growth and developmen- 
tal stages. These results also imply that the other activity 
or activities phosphorylate the same target sites that were 
originally mapped  in vitro for MHCK  A  (residues  1823, 
1833, and 2029), as removal of these target sites eliminates 
control of localization in vivo (e.g., 3X ALA myosin). 
Overall these results indicate a role for MHCK A  in reg- 
ulating myosin localization during both growth and devel- 
opment, but also indicate a role for other kinases. Further 
analysis  of  the  relative  roles  of  the  84-kD  PKC-like 
MHCK vs other partially characterized activities wilt help 
establish  the  general  mechanism  by which Dictyostelium 
cells regulate myosin function and localization. 
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